secwatch.observer — SEC 8-K summary
======================================

Issuer:     SERA PROGNOSTICS, INC. (SERA)
CIK:        0001534969
Form:       8-K
Filed at:   2023-11-08T23:59:59+00:00
Accession:  0001534969-23-000111
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sera Prognostics Q3 net loss narrows to $7.2M; appoints permanent CEO and CFO
-----------------------------------------------------------------------------

- Revenue of $42k vs $87k YoY; net loss $7.2M vs $10.7M in Q3 2022.
- Operating expenses down to $8.2M from $11.3M; cash of $85M extends runway through most of 2027.
- Board approved permanent CEO Zhenya Lindgardt and CFO Austin Aerts.
- AVERT trial shows PreTRM test drove 2.5-week gestational age improvement and 18% reduction in severe neonatal morbidity.
- New high-low risk predictor product enters next phase of market research; care coordination offering launched.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534969/000153496923000111/0001534969-23-000111-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534969/000153496923000111/sera-20231108.htm
  HTML page:      https://secwatch.observer/filing/0001534969-23-000111

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer